Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 2003, p. 2538-2544, Vol. 47, No. 8
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.8.2538-2544.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Jared A. Silverman,1* Nancy G. Perlmutter,2 and Howard M. Shapiro2
Cubist Pharmaceuticals, Inc., Lexington,1
Howard M. Shapiro, M. D., P. C., West Newton, Massachusetts2
Received 23 December 2002/
Returned for modification 17 March 2003/
Accepted 7 May 2003
The objective of this study was to further elucidate the role of membrane potential in the mechanism of action of daptomycin, a novel lipopeptide antibiotic. Membrane depolarization was measured by both fluorimetric and flow cytometric assays. Adding daptomycin (5 µg/ml) to Staphylococcus aureus gradually dissipated membrane potential. In both assays, cell viability was reduced by >99% and membrane potential was reduced by >90% within 30 min of adding daptomycin. Cell viability decreased in parallel with changes in membrane potential, demonstrating a temporal correlation between bactericidal activity and membrane depolarization. Decreases in viability and potential also showed a dose-dependent correlation. Depolarization is indicative of ion movement across the cytoplasmic membrane. Fluorescent probes were used to demonstrate Ca2+-dependent, daptomycin-triggered potassium release from S. aureus. Potassium release was also correlated with bactericidal activity. This study demonstrates a clear correlation between dissipation of membrane potential and the bactericidal activity of daptomycin. A multistep model for daptomycin's mechanism of action is proposed.
* Corresponding author. Mailing address: Cubist Pharmaceuticals, Inc., 65 Hayden Ave., Lexington, MA 02421. Phone: (781) 860-8405. Fax: (781) 861-1164. E-mail: jared.silverman{at}cubist.com.
Antimicrobial Agents and Chemotherapy, August 2003, p. 2538-2544, Vol. 47, No. 8
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.8.2538-2544.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Hobbs, J. K., Miller, K., O'Neill, A. J., Chopra, I.
(2008). Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus. J Antimicrob Chemother
62: 1003-1008
[Abstract]
[Full Text]
-
Hawkey, P. M.
(2008). Pre-clinical experience with daptomycin. J Antimicrob Chemother
62: iii7-iii14
[Abstract]
[Full Text]
-
Murthy, M. H., Olson, M. E., Wickert, R. W., Fey, P. D., Jalali, Z.
(2008). Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate. J Med Microbiol
57: 1036-1038
[Abstract]
[Full Text]
-
Cotroneo, N., Harris, R., Perlmutter, N., Beveridge, T., Silverman, J. A.
(2008). Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus. Antimicrob. Agents Chemother.
52: 2223-2225
[Abstract]
[Full Text]
-
Rose, W. E., Leonard, S. N., Sakoulas, G., Kaatz, G. W., Zervos, M. J., Sheth, A., Carpenter, C. F., Rybak, M. J.
(2008). Daptomycin Activity against Staphylococcus aureus following Vancomycin Exposure in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations. Antimicrob. Agents Chemother.
52: 831-836
[Abstract]
[Full Text]
-
Muthaiyan, A., Silverman, J. A., Jayaswal, R. K., Wilkinson, B. J.
(2008). Transcriptional Profiling Reveals that Daptomycin Induces the Staphylococcus aureus Cell Wall Stress Stimulon and Genes Responsive to Membrane Depolarization. Antimicrob. Agents Chemother.
52: 980-990
[Abstract]
[Full Text]
-
Ponticelli, C.
(2008). New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients. Nephrol Dial Transplant
23: 27-32
[Full Text]
-
Jones, T., Yeaman, M. R., Sakoulas, G., Yang, S.-J., Proctor, R. A., Sahl, H.-G., Schrenzel, J., Xiong, Y. Q., Bayer, A. S.
(2008). Failures in Clinical Treatment of Staphylococcus aureus Infection with Daptomycin Are Associated with Alterations in Surface Charge, Membrane Phospholipid Asymmetry, and Drug Binding. Antimicrob. Agents Chemother.
52: 269-278
[Abstract]
[Full Text]
-
Mascio, C. T. M., Alder, J. D., Silverman, J. A.
(2007). Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing Staphylococcus aureus Cells. Antimicrob. Agents Chemother.
51: 4255-4260
[Abstract]
[Full Text]
-
LaPlante, K. L., Mermel, L. A.
(2007). In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant
22: 2239-2246
[Abstract]
[Full Text]
-
Falagas, M. E., Giannopoulou, K. P., Ntziora, F., Vardakas, K. Z.
(2007). Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence. J Antimicrob Chemother
60: 7-19
[Abstract]
[Full Text]
-
Grandgirard, D., Schurch, C., Cottagnoud, P., Leib, S. L.
(2007). Prevention of Brain Injury by the Nonbacteriolytic Antibiotic Daptomycin in Experimental Pneumococcal Meningitis. Antimicrob. Agents Chemother.
51: 2173-2178
[Abstract]
[Full Text]
-
Benvenuto, M., Benziger, D. P., Yankelev, S., Vigliani, G.
(2006). Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy Volunteers.. Antimicrob. Agents Chemother.
50: 3245-3249
[Abstract]
[Full Text]
-
Friedman, L., Alder, J. D., Silverman, J. A.
(2006). Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus.. Antimicrob. Agents Chemother.
50: 2137-2145
[Abstract]
[Full Text]
-
Huang, V., Rybak, M. J.
(2006). Evaluation of daptomycin activity against Staphylococcus aureus in an in vitro pharmacodynamic model under normal and simulated impaired renal function. J Antimicrob Chemother
57: 116-121
[Abstract]
[Full Text]
-
Heinzelmann, E., Berger, S., Muller, C., Hartner, T., Poralla, K., Wohlleben, W., Schwartz, D.
(2005). An acyl-CoA dehydrogenase is involved in the formation of the {Delta}cis3 double bond in the acyl residue of the lipopeptide antibiotic friulimicin in Actinoplanes friuliensis. Microbiology
151: 1963-1974
[Abstract]
[Full Text]
-
Schriever, C. A., Fernandez, C., Rodvold, K. A., Danziger, L. H.
(2005). Daptomycin: A novel cyclic lipopeptide antimicrobial. Am J Health Syst Pharm
62: 1145-1158
[Abstract]
[Full Text]
-
Streit, J. M., Steenbergen, J. N., Thorne, G. M., Alder, J., Jones, R. N.
(2005). Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis. J Antimicrob Chemother
55: 574-578
[Abstract]
[Full Text]
-
Higgins, D. L., Chang, R., Debabov, D. V., Leung, J., Wu, T., Krause, K. M., Sandvik, E., Hubbard, J. M., Kaniga, K., Schmidt, D. E. Jr., Gao, Q., Cass, R. T., Karr, D. E., Benton, B. M., Humphrey, P. P.
(2005). Telavancin, a Multifunctional Lipoglycopeptide, Disrupts both Cell Wall Synthesis and Cell Membrane Integrity in Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother.
49: 1127-1134
[Abstract]
[Full Text]
-
Steenbergen, J. N., Alder, J., Thorne, G. M., Tally, F. P.
(2005). Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother
55: 283-288
[Abstract]
[Full Text]
-
Lipsky, B. A., Stoutenburgh, U.
(2005). Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections. J Antimicrob Chemother
55: 240-245
[Abstract]
[Full Text]
-
Rand, K. H., Houck, H. J.
(2004). Synergy of Daptomycin with Oxacillin and Other {beta}-Lactams against Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother.
48: 2871-2875
[Abstract]
[Full Text]
-
Streit, J. M., Jones, R. N., Sader, H. S.
(2004). Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms. J Antimicrob Chemother
53: 669-674
[Abstract]
[Full Text]
-
Rand, K. H., Houck, H.
(2004). Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci. J Antimicrob Chemother
53: 530-532
[Abstract]
[Full Text]
-
Laganas, V., Alder, J., Silverman, J. A.
(2003). In Vitro Bactericidal Activities of Daptomycin against Staphylococcus aureus and Enterococcus faecalis Are Not Mediated by Inhibition of Lipoteichoic Acid Biosynthesis. Antimicrob. Agents Chemother.
47: 2682-2684
[Abstract]
[Full Text]
Copyright © 2003 by the American Society for Microbiology. All rights reserved.